Journal article

PLX4032 (RG7204), a selective mutant RAF inhibitor: Clinical and histologic characteristics of therapy-associated cutaneous neoplasms in a phase I trial.

ME Lacouture, GA McArthur, PB Chapman, A Ribas, KT Flaherty, RJ Lee, KB Nolop, KB Kim, M Duvic, JA Sosman

Journal of Clinical Oncology | American Society of Clinical Oncology (ASCO) | Published : 2010

University of Melbourne Researchers

Citation metrics